Research

New discoveries in lung cancer research, such as the research funded by LCFA, are resulting in new treatments for lung cancer patients

How LCFA uses your donation wisely to fight lung cancer:

You Make A Donation to LCFA
Your dollars are added to contributions from other donors




We maximize your donation by adding it to dollars from LCFA’s strategic funding partners.


This leveraged donation allows LCFA to award a generous grant to a top young lung cancer investigator for 2 years of focused and intense research.


The lung cancer investigator
can now start the critical two-year process of research and discovery

Now, armed with this new evidence, the lung cancer investigator presents their findings to organizations like the National Institutes of Health (NIH) for consideration for vital next-stage grants.

Each painstaking step brings us closer to understanding how lung cancer works, how to detect it earlier, how to fight it better, and – someday – how to cure it.



Latest In Research

10/23
2018

Personalized Medicine for NTRK Fusion-Positive Solid Tumors

From Market Watch: Personalized Medicine Entrectinib Shrank Tumors in People with NTRK Fusion-Positive Solid Tumors Entrectinib showed response irrespective of tumor type or spread to the central nervous system. Data will be submitted to …

10/17
2018

Women with lung cancer live longer than men

From Helio: Women with newly diagnosed stage I to stage III non-small cell lung cancer (NSCLC) appeared to have longer overall survival than their male counterparts, according to results of a trial presented at International Association …

10/17
2018

After Decades, New Standard of Care in Small Cell Lung Cancer

From Medscape: For the first time in decades, overall survival has been shown to improve in patients with extensive-stage small cell lung cancer (ES-SCLC) when concurrent immunotherapy is added to standard chemotherapy in the first-line set…

10/9
2018

Can body fluids help spot lung cancer?

From US News Blood, saliva and even breath may one day be able to diagnose lung cancer. Lung Cancer is the no. 1 cancer killer in the U.S. "In fact, it kills more people than the next top three cancers combined," which are colorectal, brea…

09/27
2018

Air Pollution Increases Lung Cancer Risk in Nonsmokers

From MedScape Air Pollution increases lung cancer risk in nonsmokers Among persons who have never smoked, women are far more susceptible than men to develop lung cancer when exposed to air pollution, new research shows. The finding…

09/26
2018

The Power of Patients

Janet Freeman-Daily helps put patients at the center of lung cancer research. From Cancer Today Magazine IN MARCH 2011,​​ ​​​Janet Freeman-Daily had a slight but persistent cough. She was about to take a family trip to China, so …

09/25
2018

Safe, Effective Treatment for Early-Stage Lung Cancer

From EureakAlert Thermal Ablation Thermal ablation is a safe, effective treatment for early-stage lung cancer, according to a study published in the journal Radiology. The results show that ablation may be an effective alternative for patie…

09/11
2018

Anti-cancer treatment designed to lower risk of cancer’s return

New trial evaluating treatment designed to lower the risk of cancer returning Dr. Edward Garon’s Novartis CACZ885T2301 study is now open to enrollment at select TRIO- US sties. This is a randomized phase 3 study evaluating the efficacy an…

08/30
2018

Combination Therapy Study Reduces Risk of Death by Half

From Business Wire Combination Therapy Merck announced on August 20, 2018, that the U.S. Food and Drug Administration (FDA) has approved an expanded label for pembrolizumab/KEYTRUDA®, Merck’s anti-PD-1 therapy, in combination with peme…

08/28
2018

Broad-Based Testing: Will it Improve Survival?

From Cure Magazine: Broad-based genomic sequencing, is useful in identifying tumor mutations in patients with non-small cell lung cancer (NSCLC). But, it may not improve survival outcomes when compared to routine genomic testing, according t…



Read More